About Nuvaira
Nuvaira is a company based in Minneapolis (United States) founded in 2008.. Nuvaira has raised $233.15 million across 10 funding rounds from investors including USVP, Endeavour Vision and Lightstone Ventures. The company has 57 employees as of December 31, 2022. Nuvaira offers products and services including dNerva Lung Denervation System. Nuvaira operates in a competitive market with competitors including RejuvenAir, Asthmatx and D R Burton, among others.
- Headquarter Minneapolis, United States
- Employees 57 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nuvaira, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$233.15 M (USD)
in 10 rounds
-
Latest Funding Round
$15.12 M (USD), Series E
Nov 28, 2023
-
Investors
USVP
& 12 more
-
Employee Count
57
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nuvaira
Nuvaira offers a comprehensive portfolio of products and services, including dNerva Lung Denervation System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Catheter-based system for one-time lung treatment to reduce COPD symptoms.
Unlock access to complete
Unlock access to complete
Funding Insights of Nuvaira
Nuvaira has successfully raised a total of $233.15M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $15.12 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series E — $15.1M
-
First Round
First Round
(14 Apr 2009)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Series E - Nuvaira | Valuation |
investors |
|
| Jan, 2022 | Amount | Series E - Nuvaira | Valuation |
investors |
|
| Feb, 2019 | Amount | Series E - Nuvaira | Valuation | USVP , Endeavour Vision |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nuvaira
Nuvaira has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include USVP, Endeavour Vision and Lightstone Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm that focuses on early stage investments in the US
|
Founded Year | Domain | Location | |
|
Endeavour Vision is focused on transformative healthcare technology investments.
|
Founded Year | Domain | Location | |
|
Venture capital fund and fund of funds focused on the life science sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nuvaira
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nuvaira
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nuvaira Comparisons
Competitors of Nuvaira
Nuvaira operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RejuvenAir, Asthmatx and D R Burton, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cryosurgical device for chronic bronchitis and COPD treatment is developed.
|
|
| domain | founded_year | HQ Location |
Bronchial thermoplasty devices are developed for adult asthma treatment.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive products for positive pressure therapy in lung disease patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nuvaira
Frequently Asked Questions about Nuvaira
When was Nuvaira founded?
Nuvaira was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Nuvaira located?
Nuvaira is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Who is the current CEO of Nuvaira?
Dennis Wahr is the current CEO of Nuvaira.
Is Nuvaira a funded company?
Nuvaira is a funded company, having raised a total of $233.15M across 10 funding rounds to date. The company's 1st funding round was a Series E of $79M, raised on Apr 14, 2009.
How many employees does Nuvaira have?
As of Dec 31, 2022, the latest employee count at Nuvaira is 57.
What does Nuvaira do?
Nuvaira was founded in 2008 in Minneapolis, United States, within the medical device sector focused on respiratory care. Operations center on the development of the Nuvaira Lung Denervation System, a catheter-based technology for chronic obstructive pulmonary disease (COPD). This system enables Targeted Lung Denervation (TLD), a procedure by which overactive airway nerves are ablated to relieve airway obstruction and support improved breathing function.
Who are the top competitors of Nuvaira?
Nuvaira's top competitors include RejuvenAir, Asthmatx and D R Burton.
What products or services does Nuvaira offer?
Nuvaira offers dNerva Lung Denervation System.
Who are Nuvaira's investors?
Nuvaira has 13 investors. Key investors include USVP, Endeavour Vision, Lightstone Ventures, Split Rock Partners, and Advanced Technology Ventures.